Pure Biologics Spólka Akcyjna (PUR) — Capital Reinvestment Ratio
Pure Biologics Spólka Akcyjna (PUR) has a Capital Reinvestment Ratio of 0.04x as of March 2024, meaning it reinvests 0% of its operating cash flow (zł2.04 Million) in capital expenditures (zł85.00K). Check Pure Biologics Spólka Akcyjna (PUR) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pure Biologics Spólka Akcyjna Capital Reinvestment Ratio (2019–2019)
This chart tracks Pure Biologics Spólka Akcyjna's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see PUR cash flow metrics.
Annual Capital Reinvestment Ratio for Pure Biologics Spólka Akcyjna (2019–2019)
Year-by-year Capital Reinvestment Ratio for Pure Biologics Spólka Akcyjna from 2019 to 2019. See PUR FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.03x | zł5.33 Million | zł161.92K | — |